Cohort study reveals a 1.4-fold increased risk of venous thromboembolism with elevated remnant cholesterol in 107,000 individuals, suggesting a distinct lipid pathway for venous clots.
Key Points
To assess whether elevated levels of remnant cholesterol associate with an increased risk of venous thromboembolism in the general population.
Examined prospective cohort data from 107,000 individuals from the general population.
Quantified baseline remnant cholesterol concentrations and monitored incidence of venous thromboembolism over follow-up.
Elevated remnant cholesterol levels were associated with a 1.4-fold increased risk of venous thromboembolism.